Demystifying Clinical Data Transparency: Lessons learnt so far.

Beyond being required by law, data transparency in clinical trials is also an ethical and business critical aspect of drug development. Data Transparency is important to reduce avoidable burden on and/or risk to trial subjects due to the avoidance of unwarranted trial repetition, enable data-driven decisions by healthcare professionals, regulators, price selection, and pharmaceutical companies, and finally to ensure unbiased reporting of clinical trials. Throughout this Conference, we will tackle data transparency from different angles with experts from the field.

Download the programme


3 Key objectives for this Conference:
  • Enable a realistic assessment of what is required, and how these requirements could be met
  • Share information with peers as this topic is complex and dynamic and it is hard to be up-to-date on all developments
  • Establish and facilitate contacts between different players of the industry, the academic world, regulators and service providers

Event Sponsor:

EFPIA logo

Do you want to be a sponsor of the Conference?

As sponsor you will get maximum exposure before, during and after the Conference. Check out our different packages and various options


12 FEB 
Session 1: Regulatory Aspects & Updates
Session 2: Regulatory Aspects & Updates
Session 3: How are the rules lived
Session 4: Pro-active Approach
13 FEB
Session 5: Anonymisation
Session 6: Workshop around anonymisations
Session 7: The future of Data Transparency - Panel discussion

More information about the programme and the speakers will come later. Click on Keep me informed to receive further details soon! 


  • Green: Hotel NH (Grand Sablon)
  • Purple: Kwint Restaurant (dinner - Mont des arts)
  • Orange: BIP (Conference location)

PDF icon programme_flyer_sample.pdf

Book this event

Brussels, Belgium
No session currently available.
In case of interest, please contact us.